Fourth Meeting of the DS-I Africa Consortium
16 - 22 November 2024
The Ravenala Attitude Hotel, Mauritius

Mr Daniel Adediran - Participant

Helix Biogen Institute ()

Daniel Adediran is a genomics scientist interested in leveraging the use of single cell technology to unravel the molecular intricacies in ovarian, endometrial cancer. He has 2 years experience in computational development of vaccine for various infectious diseases has evidently show in his published research work of which one the candidate vaccine is presently in the pre-clinical trial phase. Daniel is passionate about using knowledge of omics to drive therapeutics solutions for various gynaecological cancers.